1
STATE OF OKLAHOMA
1
2
1st Session of the 60th Legislature (2025)
2
3
SENATE BILL 789 By: Gollihare
3
4
4
5
5
6
AS INTRODUCED
6
7
An Act relating to pharmacy benefit managers;
7
amending 59 O.S. 2021, Sections 356.2, as amended by
8
Section 2, Chapter 332, O.S.L. 2024, 357, as amended
8
by Section 4, Chapter 332, O.S.L. 2024, and 360, as
9
amended by Section 6, Chapter 332, O.S.L. 2024 (59
9
O.S. Supp. 2024, Sections 356.2, 357, and 360), which
10
relate to pharmacy audit requirements, definitions,
10
and contractual duties to provider; permitting use of
11
certain records without limitations of date or source
11
for certain purposes; modifying definitions; updating
12
statutory language; prohibiting certain network
12
sharing; establishing certain reimbursement rates for
13
certain drugs; providing for fee increase;
13
prohibiting certain contracts between certain
14
parties; establishing penalties; disallowing
14
contracts from violating certain provisions; and
15
providing an effective date.
15
16
16
17
17
18
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
18
19
SECTION 1. AMENDATORY 59 O.S. 2021, Section 356.2, as
19
20
amended by Section 2, Chapter 332, O.S.L. 2024 (59 O.S. Supp. 2024,
20
21
Section 356.2), is amended to read as follows:
21
22
Section 356.2. A. The entity conducting an audit of a pharmacy
22
23
shall:
23
24
24
Req. No. 700 Page 1

1
1. Identify and specifically describe the audit and appeal
1
2
procedures in the pharmacy contract. Prescription claim
2
3
documentation and record-keeping requirements shall not exceed the
3
4
requirements set forth by the Oklahoma Pharmacy Act or other
4
5
applicable state or federal laws or regulations;
5
6
2. Give the pharmacy written notice by certified letter to the
6
7
pharmacy and the pharmacy’s contracting agent, including
7
8
identification of specific prescription numbers and fill dates to be
8
9
audited, at least fourteen (14) calendar days prior to conducting
9
10
the audit, including, but not limited to, an on-site audit, a desk
10
11
audit, or a wholesale purchase audit, request for documentation
11
12
related to the dispensing of a prescription drug or any reimbursed
12
13
activity by a pharmacy provider; provided, however, that wholesale
13
14
purchase audits shall require a minimum of thirty (30) calendar
14
15
days’ written notice. For an on-site audit, the audit date shall be
15
16
the date the on-site audit occurs. For all other audit types, the
16
17
audit date shall be the date the pharmacy provides the documentation
17
18
requested in the audit notice. The pharmacy shall have the
18
19
opportunity to reschedule the audit no more than seven (7) calendar
19
20
days from the date designated on the original audit notification;
20
21
3. Not interfere with the delivery of pharmacist services to a
21
22
patient and shall utilize every reasonable effort to minimize
22
23
inconvenience and disruption to pharmacy operations during the audit
23
24
process;
24
Req. No. 700 Page 2

1
4. Conduct any audit involving clinical or professional
1
2
judgment by means of or in consultation with a licensed pharmacist;
2
3
5. Not consider as fraud any clerical or record-keeping error,
3
4
such as a typographical error, scrivener’s error or computer error,
4
5
including, but not limited to, a miscalculated day supply,
5
6
incorrectly billed prescription written date or prescription origin
6
7
code, and such errors shall not be subject to recoupment. The
7
8
pharmacy shall have the right to submit amended claims
8
9
electronically to correct clerical or record-keeping errors in lieu
9
10
of recoupment. To the extent that an audit results in the
10
11
identification of any clerical or record-keeping errors such as
11
12
typographical errors, scrivener’s errors or computer errors in a
12
13
required document or record, the pharmacy shall not be subject to
13
14
recoupment of funds by the pharmacy benefits manager unless the
14
15
pharmacy benefits manager can provide proof of intent to commit
15
16
fraud. A person shall not be subject to criminal penalties for
16
17
errors provided for in this paragraph without proof of intent to
17
18
commit fraud;
18
19
6. Permit a pharmacy to use the records of a hospital,
19
20
physician, or other authorized practitioner of the healing arts for
20
21
drugs or medicinal supplies written or transmitted by any means of
21
22
communication for purposes of validating the pharmacy record with
22
23
respect to orders or refills of a legend or narcotic drug;
23
24
24
Req. No. 700 Page 3

1
7. Permit a pharmacy to use drug purchase records without
1
2
limitation of date or source to validate the dispensing of a
2
3
prescription drug or a controlled dangerous substance, provided the
3
4
drug purchase was done in accordance with state or federal law;
4
5
8. Not include the dispensing fee amount or the actual invoice
5
6
cost of the prescription dispensed in a finding of an audit
6
7
recoupment unless a prescription was not actually dispensed or a
7
8
physician denied authorization of a dispensing order;
8
9
8. 9. Audit each pharmacy under identical standards, regularity
9
10
and parameters as other similarly situated pharmacies and all
10
11
pharmacies owned or managed by the pharmacy benefits manager
11
12
conducting or having conducted the audit;
12
13
9. 10. Not exceed one (1) year from the date the claim was
13
14
submitted to or adjudicated by a managed care company, nonprofit
14
15
hospital or medical service organization, insurance company, third-
15
16
party payor, pharmacy benefits manager, a health program
16
17
administered by a department of this state, or any entity that
17
18
represents the companies, groups, or departments for the period
18
19
covered by an audit;
19
20
10. 11. Not schedule or initiate an audit during the first
20
21
seven (7) calendar days of any month unless otherwise consented to
21
22
by the pharmacy;
22
23
11. 12. Disclose to any plan sponsor whose claims were included
23
24
in the audit any money recouped in the audit;
24
Req. No. 700 Page 4

1
12. 13. Not require pharmacists to break open packaging labeled
1
2
“for single-patient-use only”. Packaging labeled “for single-
2
3
patient-use only” shall be deemed to be the smallest package size
3
4
available; and
4
5
13. 14. Upon recoupment of funds from a pharmacy, refund first
5
6
to the patient the portion of the recovered funds that were
6
7
originally paid by the patient, provided such funds were part of the
7
8
recoupment.
8
9
B. 1. Any entity that conducts wholesale purchase review
9
10
during an audit of a pharmacist or pharmacy shall not require the
10
11
pharmacist or pharmacy to provide a full dispensing report.
11
12
Wholesaler invoice reviews shall be limited to verification of
12
13
purchase inventory specific to the pharmacy claims paid by the
13
14
health benefits plan or pharmacy benefits manager conducting the
14
15
audit without limitation to date or source of purchase.
15
16
2. Any entity conducting an audit shall not identify or label a
16
17
prescription claim as an audit discrepancy when:
17
18
a. the National Drug Code for the dispensed drug is in a
18
19
quantity that is a subunit or multiple of the drug
19
20
purchased by the pharmacist or pharmacy as supported
20
21
by a wholesale invoice,
21
22
b. the pharmacist or pharmacy dispensed the correct
22
23
quantity of the drug according to the prescription,
23
24
and
24
Req. No. 700 Page 5

1
c. the drug dispensed by the pharmacist or pharmacy
1
2
shares all but the last two digits of the National
2
3
Drug Code of the drug reflected on the supplier
3
4
invoice.
4
5
3. An entity conducting an audit shall accept as evidence,
5
6
without limitation on date or source of purchase subject to
6
7
validation, to support the validity of a pharmacy claim related to a
7
8
dispensed drug:
8
9
a. redacted copies of supplier invoices in the
9
10
pharmacist’s or pharmacy’s possession, or
10
11
b. invoices and any supporting documents from any
11
12
supplier as authorized by federal or state law to
12
13
transfer ownership of the drug acquired by the
13
14
pharmacist or pharmacy.
14
15
4. An entity conducting an audit shall provide, no later than
15
16
five (5) calendar days after the date of a request by the pharmacist
16
17
or pharmacy, all supporting documents the pharmacist’s or pharmacy’s
17
18
purchase suppliers provided to the health benefits plan issuer or
18
19
pharmacy benefits manager.
19
20
C. A pharmacy shall be allowed to provide the pharmacy’s
20
21
computerized patterned medical records or the records of a hospital,
21
22
physician, or other authorized practitioner of the healing arts for
22
23
drugs or medicinal supplies written or transmitted by any means of
23
24
24
Req. No. 700 Page 6

1
communication for purposes of supporting the pharmacy record with
1
2
respect to orders or refills of a legend or narcotic drug.
2
3
D. The entity conducting the audit shall not audit more than
3
4
fifty prescriptions, with specific date of service, per calendar
4
5
year. The annual limit to the number of prescription claims audited
5
6
shall be inclusive of all audits, including any prescription-related
6
7
documentation requests from the health insurer, pharmacy benefits
7
8
manager or any third-party company conducting audits on behalf of
8
9
any health insurer or pharmacy benefits manager during a calendar
9
10
year.
10
11
E. If paper copies of records are requested by the entity
11
12
conducting the audit, the entity shall pay twenty-five cents ($0.25)
12
13
per page to cover the costs incurred by the pharmacy. The entity
13
14
conducting the audit shall provide the pharmacy with accurate
14
15
instructions, including any required form for obtaining
15
16
reimbursement for the copied records.
16
17
F. The entity conducting the audit shall:
17
18
1. Deliver a preliminary audit findings report to the pharmacy
18
19
and the pharmacy’s contracting agent within forty-five (45) calendar
19
20
days of conducting the audit;
20
21
2. Allow the pharmacy at least ninety (90) calendar days
21
22
following receipt of the preliminary audit findings report in which
22
23
to produce documentation to address any discrepancy found during the
23
24
24
Req. No. 700 Page 7

1
audit; provided, however, a pharmacy may request an extension, not
1
2
to exceed an additional forty-five (45) calendar days;
2
3
3. Deliver a final audit findings report to the pharmacy and
3
4
the pharmacy’s contracting agent signed by the auditor within ten
4
5
(10) calendar days after receipt of additional documentation
5
6
provided by the pharmacy, as provided for in Section 356.3 of this
6
7
title;
7
8
4. Allow the pharmacy to reverse and resubmit claims
8
9
electronically within thirty (30) calendar days of receipt of the
9
10
final audit report in lieu of the auditing entity recouping
10
11
discrepant claim amounts from the pharmacy;
11
12
5. Not recoup any disputed funds until after final disposition
12
13
of the audit findings, including the appeals process as provided for
13
14
in Section 356.3 of this title; and
14
15
6. Not accrue interest during the audit and appeal period.
15
16
G. Each entity conducting an audit shall provide a copy of the
16
17
final audit results, and a final audit report upon request, after
17
18
completion of any review process to the plan sponsor.
18
19
H. 1. The full amount of any recoupment on an audit shall be
19
20
refunded to the plan sponsor. Except as provided for in paragraph 2
20
21
of this subsection, a charge or assessment for an audit shall not be
21
22
based, directly or indirectly, on amounts recouped.
22
23
2. This subsection does not prevent the entity conducting the
23
24
audit from charging or assessing the responsible party, directly or
24
Req. No. 700 Page 8

1
indirectly, based on amounts recouped if both of the following
1
2
conditions are met:
2
3
a. the plan sponsor and the entity conducting the audit
3
4
have a contract that explicitly states the percentage
4
5
charge or assessment to the plan sponsor, and
5
6
b. a commission to an agent or employee of the entity
6
7
conducting the audit is not based, directly or
7
8
indirectly, on amounts recouped.
8
9
I. Unless superseded by state or federal law, auditors shall
9
10
only have access to previous audit reports on a particular pharmacy
10
11
conducted by the auditing entity for the same pharmacy benefits
11
12
manager, health plan or insurer. An auditing vendor contracting
12
13
with multiple pharmacy benefits managers or health insurance plans
13
14
shall not use audit reports or other information gained from an
14
15
audit on a pharmacy to conduct another audit for a different
15
16
pharmacy benefits manager or health insurance plan.
16
17
J. Sections A through I of this section shall not apply to any
17
18
audit initiated based on or that involves fraud, willful
18
19
misrepresentation, or abuse.
19
20
K. If the Attorney General, after notice and opportunity for
20
21
hearing, finds that the entity conducting the audit failed to follow
21
22
any of the requirements pursuant to the Pharmacy Audit Integrity
22
23
Act, the audit shall be considered null and void. Any monies
23
24
recouped from a null and void audit shall be returned to the
24
Req. No. 700 Page 9

1
affected pharmacy within fourteen (14) calendar days. Any violation
1
2
of this section by a pharmacy benefits manager or auditing entity
2
3
shall be deemed a violation of the Pharmacy Audit Integrity Act.
3
4
SECTION 2. AMENDATORY 59 O.S. 2021, Section 357, as
4
5
amended by Section 4, Chapter 332, O.S.L. 2024 (59 O.S. Supp. 2024,
5
6
Section 357), is amended to read as follows:
6
7
Section 357. A. As used in Sections 357 through 360 of this
7
8
title:
8
9
1. “Covered entity” means a nonprofit hospital or medical
9
10
service organization, for-profit hospital or medical service
10
11
organization, insurer, health benefit plan, health maintenance
11
12
organization, health program administered by the state in the
12
13
capacity of providing health coverage, or an employer, labor union,
13
14
or other group of persons that provides health coverage to persons
14
15
in this state. This term does not include a health benefit plan
15
16
that provides coverage only for accidental injury, specified
16
17
disease, hospital indemnity, disability income, or other limited
17
18
benefit health insurance policies and contracts that do not include
18
19
prescription drug coverage;
19
20
2. “Covered individual” means a member, participant, enrollee,
20
21
contract holder or policy holder or beneficiary of a covered entity
21
22
who is provided health coverage by the covered entity. A covered
22
23
individual includes any dependent or other person provided health
23
24
24
Req. No. 700 Page 10

1
coverage through a policy, contract or plan for a covered
1
2
individual;
2
3
3. “Department” means the Insurance Department;
3
4
4. “Effective rate contracting” means any agreement or
4
5
arrangement between a pharmacy or contracting agent acting on behalf
5
6
of a pharmacy and a pharmacy benefits manager for pharmaceuticals
6
7
based on the effective rate of payment rather than a predetermined
7
8
fixed price or fixed discount percentage;
8
9
5. “Maximum allowable cost”, “MAC”, or “MAC list” means the
9
10
list of drug products delineating the maximum per-unit reimbursement
10
11
for multiple-source prescription drugs, medical product, or device;
11
12
5. 6. “Multisource drug product reimbursement” (reimbursement)
12
13
means the total amount paid to a pharmacy inclusive of any reduction
13
14
in payment to the pharmacy, excluding prescription dispense fees and
14
15
professional fees;
15
16
6. 7. “Office” means the Office of the Attorney General;
16
17
7. 8. “Pharmacy benefits management” means a service provided
17
18
to covered entities to facilitate the provision of prescription drug
18
19
benefits to covered individuals within the state, including
19
20
negotiating pricing and other terms with drug manufacturers and
20
21
providers. Pharmacy benefits management may include any or all of
21
22
the following services:
22
23
23
24
24
Req. No. 700 Page 11

1
a. claims processing, retail network management and
1
2
payment of claims to pharmacies for prescription drugs
2
3
dispensed to covered individuals,
3
4
b. clinical formulary development and management
4
5
services, or
5
6
c. rebate contracting and administration;
6
7
8. 9. “Pharmacy benefits manager” or “PBM” means a person,
7
8
business, or other entity that performs pharmacy benefits
8
9
management. The term shall include a person or entity acting on
9
10
behalf of a PBM in a contractual or employment relationship in the
10
11
performance of pharmacy benefits management for a managed care
11
12
company, nonprofit hospital, medical service organization, insurance
12
13
company, third-party payor, or a health program administered by an
13
14
agency or department of this state;
14
15
9. 10. “Plan sponsor” means the employers, insurance companies,
15
16
unions and health maintenance organizations or any other entity
16
17
responsible for establishing, maintaining, or administering a health
17
18
benefit plan on behalf of covered individuals; and
18
19
10. 11. “Provider” means a pharmacy licensed by the State Board
19
20
of Pharmacy, or an agent or representative of a pharmacy, including,
20
21
but not limited to, the pharmacy’s contracting agent, which
21
22
dispenses prescription drugs or devices to covered individuals.
22
23
B. Nothing in the definition of pharmacy benefits management or
23
24
pharmacy benefits manager in the Patient’s Right to Pharmacy Choice
24
Req. No. 700 Page 12

1
Act, Pharmacy Audit Integrity Act, or Sections 357 through 360 of
1
2
this title shall deem an employer a “pharmacy benefits manager” of
2
3
its own self-funded health benefit plan, except, to the extent
3
4
permitted by applicable law, where the employer, without the
4
5
utilization of a third party and unrelated to the employer’s own
5
6
pharmacy:
6
7
a. negotiates directly with drug manufacturers,
7
8
b. processes claims on behalf of its members, or
8
9
c. manages its own retail network of pharmacies.
9
10
SECTION 3. AMENDATORY 59 O.S. 2021, Section 360, as
10
11
amended by Section 6, Chapter 332, O.S.L. 2024 (59 O.S. Supp. 2024,
11
12
Section 360), is amended to read as follows:
12
13
Section 360. A. The pharmacy benefits manager shall, with
13
14
respect to contracts between a pharmacy benefits manager and a
14
15
provider, including a pharmacy service administrative organization:
15
16
l. Include in such contracts the specific sources utilized to
16
17
determine the maximum allowable cost (MAC) pricing of the pharmacy,
17
18
update MAC pricing at least every seven (7) calendar days, and
18
19
establish a process for providers to readily access the MAC list
19
20
specific to that provider;
20
21
2. In order to place a drug on the MAC list, ensure that the
21
22
drug is listed as “A” or “B” rated in the most recent version of the
22
23
FDA’s Approved Drug Products with Therapeutic Equivalence
23
24
Evaluations, also known as the Orange Book, and the drug is
24
Req. No. 700 Page 13

1
generally available for purchase by pharmacies in the state from
1
2
national or regional wholesalers and is not obsolete;
2
3
3. Ensure dispensing fees are not included in the calculation
3
4
of MAC price reimbursement to pharmacy providers;
4
5
4. Provide a reasonable administration appeals procedure to
5
6
allow a provider, a provider’s representative and a pharmacy service
6
7
administrative organization to contest reimbursement amounts within
7
8
fourteen (14) calendar days of the final adjusted payment date. The
8
9
pharmacy benefits manager shall not prevent the pharmacy or the
9
10
pharmacy service administrative organization from filing
10
11
reimbursement appeals in an electronic batch format. The pharmacy
11
12
benefits manager must respond to a provider, a provider’s
12
13
representative and a pharmacy service administrative organization
13
14
who have contested a reimbursement amount through this procedure
14
15
within ten (10) calendar days. The pharmacy benefits manager must
15
16
respond in an electronic batch format to reimbursement appeals filed
16
17
in an electronic batch format. The pharmacy benefits manager shall
17
18
not require a pharmacy or pharmacy services administrative
18
19
organization to log into a system to upload individual claim appeals
19
20
or to download individual appeal responses. If a price update is
20
21
warranted, the pharmacy benefits manager shall make the change in
21
22
the reimbursement amount, permit the dispensing pharmacy to reverse
22
23
and rebill the claim in question, and make the reimbursement amount
23
24
change retroactive and effective for all contracted providers; and
24
Req. No. 700 Page 14

1
5. If a below-cost reimbursement appeal is denied, the PBM
1
2
shall provide the reason for the denial, including the National Drug
2
3
Code (NDC) number from, and the name of, the specific national or
3
4
regional wholesalers doing business in this state where the drug is
4
5
currently in stock and available for purchase by the dispensing
5
6
pharmacy at a price below the PBM’s reimbursement price. If the NDC
6
7
number provided by the pharmacy benefits manager is not available
7
8
below the acquisition cost obtained from the pharmaceutical
8
9
wholesaler from whom the dispensing pharmacy purchases the majority
9
10
of the prescription drugs that are dispensed, the pharmacy benefits
10
11
manager shall immediately adjust the reimbursement amount, permit
11
12
the dispensing pharmacy to reverse and rebill the claim in question,
12
13
and make the reimbursement amount adjustment retroactive and
13
14
effective in effect for all contracted providers for future claims
14
15
billed.
15
16
B. The reimbursement appeal requirements in this section shall
16
17
apply to all drugs, medical products, or devices reimbursed
17
18
according to any payment methodology, including, but not limited to:
18
19
1. Average acquisition cost, including the National Average
19
20
Drug Acquisition Cost;
20
21
2. Average manufacturer price;
21
22
3. Average wholesale price;
22
23
4. Brand effective rate or generic effective rate;
23
24
5. Discount indexing;
24
Req. No. 700 Page 15

1
6. Federal upper limits;
1
2
7. Wholesale acquisition cost; and
2
3
8. Any other term that a pharmacy benefits manager or an
3
4
insurer of a health benefit plan may use to establish reimbursement
4
5
rates to a pharmacist or pharmacy for pharmacist services.
5
6
C. The pharmacy benefits manager shall not place a drug on a
6
7
MAC list, unless there are at least two therapeutically equivalent,
7
8
multiple-source drugs, generally available for purchase by
8
9
dispensing retail pharmacies from national or regional wholesalers.
9
10
D. In the event that a drug is placed on the FDA Drug Shortages
10
11
Database, pharmacy benefits managers shall reimburse claims to
11
12
pharmacies at no less than the wholesale acquisition cost for the
12
13
specific NDC number being dispensed.
13
14
E. The pharmacy benefits manager shall not require
14
15
accreditation or licensing of providers, or any entity licensed or
15
16
regulated by the State Board of Pharmacy, other than by the State
16
17
Board of Pharmacy or federal government entity as a condition for
17
18
participation as a network provider.
18
19
F. A pharmacy or pharmacist may decline to provide the
19
20
pharmacist clinical or dispensing services to a patient or pharmacy
20
21
benefits manager if the pharmacy or pharmacist is to be paid less
21
22
than the pharmacy’s cost for providing the pharmacist clinical or
22
23
dispensing services.
23
24
24
Req. No. 700 Page 16

1
G. The pharmacy benefits manager shall provide a dedicated
1
2
telephone number, email address and names of the personnel with
2
3
decision-making authority regarding MAC appeals and pricing.
3
4
H. No pharmacy benefits manager (PBM) shall lease, rent, or
4
5
otherwise make its provider network available to another pharmacy
5
6
benefits manager. Prohibited activities shall include, but not be
6
7
limited to:
7
8
1. Entering into agreements or contracts that allow another PBM
8
9
to use the provider network; and
9
10
2. Facilitating access to the provider network though any form
10
11
of leasing or renting arrangement.
11
12
I. The PBM shall, with respect to contracts between a PBM and a
12
13
provider, including contracts with pharmacy service administrative
13
14
organization, ensure that reimbursement to pharmacies for each drug
14
15
dispensed is no less than one hundred six percent (106%) of the
15
16
National Average Drug Acquisition Cost (NADAC) plus a professional
16
17
fee of Fifteen Dollars ($15.00). The NADAC price shall be the price
17
18
published in effect for the date the drug claim was billed by the
18
19
pharmacy. If a particular drug does not have a published NADAC
19
20
price, the reimbursement shall be one hundred ten percent (110%) of
20
21
the wholesale acquisition cost (WAC) plus a professional fee of
21
22
Fifteen Dollars ($15.00) for generic drugs and one hundred (100%)
22
23
percent of the WAC plus a professional fee of Fifteen Dollars
23
24
($15.00) for brand-name drugs. The professional fee shall
24
Req. No. 700 Page 17

1
automatically increase on January 1 of each year at a percentage
1
2
equal to the inflation rate measured by the Consumer Price Index for
2
3
the previous twelve-month period.
3
4
J. 1. Effective rate contracting is hereby prohibited in all
4
5
agreements between pharmacies or contracting agents acting on behalf
5
6
of a pharmacy and a PBM or third-party payers. No PBM or third-
6
7
party payer shall enter into any contract that establishes payment
7
8
for services or medications based on an effective rate of
8
9
reimbursement.
9
10
2. Any PBM or third-party payer found to be in violation of
10
11
this section shall be subject to penalties, including, but not
11
12
limited to, fines, revocation of licensure, or other disciplinary
12
13
actions.
13
14
K. The provisions of this section shall not be waived, voided,
14
15
or nullified by contract.
15
16
SECTION 4. This act shall become effective November 1, 2025.
16
17
17
18
60-1-700 CAD 1/19/2025 5:43:20 AM
18
19
19
20
20
21
21
22
22
23
23
24
24
Req. No. 700 Page 18

[DELETED:  P B G]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P t t]
[DELETED:  P t r i]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P t a]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P c c r]
[DELETED:  P n p m]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P]
[DELETED:  P C 1]